The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IκB-α stimulated by tumour necrosis factor-α in cultured vascular smooth muscle cells.

[1]  G. Grassia,et al.  Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation. , 2011, Atherosclerosis.

[2]  F. Weih,et al.  Mouse Aorta Smooth Muscle Cells Differentiate Into Lymphoid Tissue Organizer-Like Cells on Combined Tumor Necrosis Factor Receptor-1/Lymphotoxin &bgr;-Receptor NF-&kgr;B Signaling , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[3]  C. Yutani,et al.  HVJ-AVE liposome-mediated Tissue Factor Pathway Inhibitor (TFPI) gene transfer with recombinant TFPI (rTFPI) irrigation attenuates restenosis in atherosclerotic arteries. , 2009, International journal of cardiology.

[4]  Jing Hu,et al.  Adenovirus-mediated gene transfer of tissue factor pathway inhibitor induces apoptosis in vascular smooth muscle cells , 2008, Apoptosis.

[5]  C. Gondi,et al.  Restoration of Tissue Factor Pathway Inhibitor-2 in a Human Glioblastoma Cell Line Triggers Caspase-Mediated Pathway and Apoptosis , 2007, Clinical Cancer Research.

[6]  M. Mack,et al.  Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. , 2007, The Journal of clinical investigation.

[7]  N. Weissman,et al.  An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy. , 2006, American Journal of Cardiology.

[8]  P. Bass,et al.  Tissue factor pathway inhibitor: structure, biology and involvement in disease , 2006, The Journal of pathology.

[9]  Ji Young Kim,et al.  Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques. , 2004, Biochemical and biophysical research communications.

[10]  H. Bergmeister,et al.  Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. , 2004, Blood.

[11]  P. Carmeliet,et al.  The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. , 2003, The American journal of pathology.

[12]  Y. Kaneda,et al.  Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. , 2002, Cardiovascular research.

[13]  H. Kato.  Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[14]  T. Ohe,et al.  Anti-inflammatory effects of long-lasting locally-delivered human recombinant tissue factor pathway inhibitor after balloon angioplasty , 2002, Basic Research in Cardiology.

[15]  R. Simari,et al.  Role for Tissue Factor Pathway in Murine Model of Vascular Remodeling , 2001, Circulation research.

[16]  J. Willerson,et al.  Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Takeshita,et al.  Combination of a Brief Irrigation With Tissue Factor Pathway Inhibitor (TFPI) and Adenovirus-Mediated Local TFPI Gene Transfer Additively Reduces Neointima Formation in Balloon-Injured Rabbit Carotid Arteries , 2001, Circulation.

[18]  T. Yue,et al.  Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. , 2000, Biochimica et biophysica acta.

[19]  Y. Asada,et al.  Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor/factor VIIa complex. , 1999, Thrombosis research.

[20]  A. Roach,et al.  Human vascular smooth muscle cells express receptors for CC chemokines. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[21]  K. Hatakeyama,et al.  Tissue Factor Pathway Inhibitor Inhibits Aortic Smooth Muscle Cell Migration Induced by Tissue Factor/Factor VIIa Complex , 1997, Thrombosis and Haemostasis.

[22]  E. Topol,et al.  Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. , 1997, Progress in cardiovascular diseases.

[23]  Y. Kamikubo,et al.  Human recombinant tissue‐factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells , 1997, FEBS letters.

[24]  M. Leon,et al.  Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. , 1997, Circulation.

[25]  T. Nakajima,et al.  Thrombin Activates NF‐κB through Thrombin Receptor and Results in Proliferation of Vascular Smooth Muscle Cells: Role of Thrombin in Atherosclerosis and Restenosis , 1997, Annals of the New York Academy of Sciences.